US › Healthcare

Elutia Inc. (ELUT)

US · Healthcare · Medical Devices

$0.79+0.66%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$2.4M

Revenue YoY

-61.2%

Net profit

$-7.6M

EPS

$-0.17

EPS estimate

$-0.15

Net margin

-315.0%

EPS came in at -0.17 against a street estimate of -0.15 — a miss of 13.3%.

Key statistics

Market cap

$35.2M

Forward P/E

0.0

P/B

2.44

Book value

$0.36

EPS (TTM)

$-0.64

52-week high

$1.39

52-week low

$0.50

50-day MA

$0.84

200-day MA

$0.97

Beta

0.84

Analyst view

Analysts rate Elutia Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $5.00.

Shareholding

Insiders

3.58%

Institutions

43.82%

Largest institutional holders

Fund	Stake
Nantahala Capital Management, LLC	14.38%
AIGH Capital Management, LLC	6.09%
Knollwood Investment Advisory LLC	5.77%
SILVERARC CAPITAL MANAGEMENT, LLC	4.95%
Vanguard Capital Management, LLC	2.58%
Perkins Capital Management Inc	1.57%
Geode Capital Management, LLC	0.64%
CI Private Wealth LLC	0.57%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Elutia Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.